SCHEMBL7521604

SCHEMBL7521604

COC(=O)CCc1cc(-n2nc3ccc(Cl)cc3n2)c(O)c(C(C)(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.42
MAOB P27338 3/20 0.37
MAOA P21397 2/20 0.37
EGFR P00533 1/20 0.37
ADORA3 P0DMS8 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ACHE P22303 1/20 0.35
POLB P06746 1/20 0.35
CYP11B1 P15538 2/20 0.34
CYP11B2 P19099 2/20 0.34
PLA2G2A P14555 2/20 0.34
MAPT P10636 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
ALOX15 P16050 1/20 0.34
MAPK1 P28482 1/20 0.34
GAA P10253 1/20 0.34
TBXAS1 P24557 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5835062 0.93 KDM4E (0.42) KDM4EMAOBMAOAEGFRADORA3
SCHEMBL7527995 0.92 KDM4E (0.41) KDM4EMAOBMAOASMN1; SMN2ACHE
SCHEMBL1896797 0.90 MAOB (0.42) KDM4EMAOBMAOAEGFRADORA3
SCHEMBL78795 0.89 GAA (0.42) KDM4EMAOBMAOAEGFRADORA3
SCHEMBL29664175 0.89 GAA (0.42) KDM4EMAOBMAOAEGFRADORA3
SCHEMBL7523053 0.89 KDM4E (0.35) KDM4EMAOBMAOASMN1; SMN2ACHE
SCHEMBL6862492 0.87 KDM4E (0.38) KDM4EMAOBMAOAEGFRADORA3
SCHEMBL7528216 0.87 EPHX2 (0.40) KDM4EALDH1A1HPGD
SCHEMBL29142799 0.87 KDM4E (0.47) KDM4EEGFRADORA3SMN1; SMN2POLB
SCHEMBL5834041 0.83 KDM4E (0.38) KDM4EMAOBMAOAADORA3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6489383-B1 SUCH AS 2-(2-HYDROXY-3-(1,1-DI(4-2-(BROMOETHOXY)PHENYL) ETHYL)-5-TERT-BUTYLPHENYL)-2H-BENZOTRIAZOLE FOR USE AS STOVING LACQUER, FINISHING ENAMEL FOR AUTOMOBILES CIBA SPECIALTY CHEMICALS CORPORATION 2002-12-03 US disclosed
US-20020169239-A1 2H-benzotriazole UV absorbers substituted with 1,1-diphenylakyl groups and compositions stabilized therewith WOOD MERVIN G (US) 2002-11-14 US disclosed
US-6392056-B1 FOR THERMOPLASTIC RESINS CIBA SPECIALTY CHEMICAL CORPORATION 2002-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020169239-A1 2H-benzotriazole UV absorbers substituted with 1,1-diphenylakyl groups and compositions stabilized therewith SUV39H1, SUV39H2, PAH KDM4E 175/4885MAOB 3309/4885MAOA 2378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.